Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-08-16FDA Approved: IPRATROPIUM BROMIDE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's generic ipratropium bromide as an Original Application (ANDA). It is indicated for COPD-related…
-
FDA approval · 2022-08-16FDA Approved: IPRATROPIUM BROMIDE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved the original ANDA for ipratropium bromide as a generic inhalation product from Amneal Pharmaceuticals NY LLC.
-
CLINICAL_TRIALS trial_result · 2022-08-01Clinical Trial Update: Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1) [NA]
Completed pragmatic trial evaluating methods to improve communication about serious illness; results have been posted (2022-08-01).
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: A Study of RPL554 Drug Administered by Metered Dose Inhaler to Treat Chronic Obstructive Pulmonary Disease [Phase 2]
A Phase 2 study evaluating RPL554 delivered via metered dose inhaler for chronic obstructive pulmonary disease has completed and posted resu…
-
CLINICAL_TRIALS trial_result · 2022-07-22Clinical Trial Update: At Home Spirometry and Video Module Education for COPD Patients [NA]
A completed clinical trial evaluating at-home spirometry and video module education for COPD patients; results posted in 2022.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: Efficacy and Safety Comparison of Tiotropium Daily + Salmeterol Daily or Twice Daily Versus Tiotropium Daily in Patients With COPD [Phase 3]
Phase 3 trial comparing tiotropium daily + salmeterol daily versus tiotropium daily (and tiotropium daily twice daily) in COPD; completed wi…
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: Residential Cleaning of Indoor Air to Protect COPD Patients [NA]
Clinical trial about residential air cleaning to protect COPD patients has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: The Use of Aeriseal ® in the Management of Collateral Ventilation Positive COPD Patients Undergoing ELVR Utilizing Endobronchial Valves. [Phase 2]
Phase 2 clinical trial evaluating Aeriseal in COPD patients with collateral ventilation undergoing endobronchial valve–assisted lung volume …
-
FDA approval · 2022-05-26FDA Approved: ARFORMOTEROL TARTRATE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved the original application for ARFORMOTEROL TARTRATE (arformoterol tartrate) by Sun Pharmaceutical Industries, Inc., a generi…
-
FDA approval · 2022-05-25FDA Approved: YUPELRI — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for YUPELRI (revefenacin) from Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: Anti-ST2 (MSTT1041A) in COPD (COPD-ST2OP) [Phase 2]
Phase 2 trial update for anti-ST2 (MSTT1041A) in COPD with a completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2022-05-20Clinical Trial Update: Salmeterol/Fluticasone 50/500 mcg Inhalation Powder Via Capsair vs Seretide Diskus 500 mcg Inhalation Powder in Patients With COPD [Phase 4]
Phase 4 trial comparing Salmeterol/Fluticasone 50/500 mcg inhalation powder via Capsair vs Seretide Diskus 500 mcg in COPD; study terminated…
-
FDA approval · 2022-05-11FDA Approved: TRELEGY ELLIPTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for TRELEGY ELLIPTA submitted by GlaxoSmithKline LLC.
-
FDA approval · 2022-05-10FDA Approved: ARFORMOTEROL TARTRATE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' original generic application for arformoterol tartrate, a bronchodilator used to treat chronic obstruc…
-
FDA approval · 2022-05-10FDA Approved: ROFLUMILAST — Original Application (Solco Healthcare US, LLC.)
FDA approved the original ANDA for roflumilast by Solco Healthcare US, LLC, authorizing a generic version of the COPD medication.
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Efficacy and Safety of ICS/LABA vs. LAMA/LABA in Patients With Different COPD Phenotypes. [Phase 4]
A Phase 4 trial comparing ICS/LABA versus LAMA/LABA in COPD patients to assess efficacy and safety across different COPD phenotypes.
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo. [Phase 2]
A Phase 2 trial evaluating alvelestat (MPH966) versus placebo in participants with alpha1-antitrypsin-related COPD has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Pulmonary Rehab in Chronic Obstructive Pulmonary Disease (COPD): Response to Tyvaso [Phase 2]
Phase 2 trial update on pulmonary rehabilitation in COPD; study terminated with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Disease (COPD)
A completed clinical trial in South Korea used medical records to compare different treatments for chronic obstructive pulmonary disease (CO…
-
FDA approval · 2022-03-31FDA Approved: WIXELA INHUB — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved Mylan's supplemental application for WIXELA INHUB, a generic inhaled corticosteroid/long-acting beta-agonist combination (fluti…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Manual Therapy in Addition to Pulmonary Rehabilitation in Moderate Chronic Obstructive Pulmonary Disease. [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating manual therapy in addition to pulmonary rehabilitation for moderate chronic obstructive pulmonary dise…
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: The Study for Evaluating the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath'(COPD, Asthma, Lung Cancer, Etc.) [Phase 3]
A Phase 3 trial update for a respiratory rehabilitation software called Redpill Breath, evaluating its clinical effectiveness and safety in …
-
CLINICAL_TRIALS trial_result · 2022-03-18Clinical Trial Update: Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing. [Phase 3]
A Phase 3 trial compared two inhaler combinations of budesonide/formoterol to determine which provides better breathing improvement in COPD;…
-
FDA approval · 2022-03-15FDA Approved: BREYNA — Original Application (Mylan Pharmaceuticals Inc.)
The FDA approved Breyna, a generic budesonide/formoterol fumarate inhalation product from Mylan, as an original application.
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: A Study in Taiwan Based on Medical Records That Looks at the Occurrence of Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Started LABA/LAMA or LAMA Treatment
A completed clinical trial in Taiwan examined COPD flare-ups in patients who started LABA/LAMA or LAMA therapy based on medical records.